Coatue’s AI Master Plan: Chips, Power, and the New Token Economy
Coatue has evolved from a tech hedge fund into an AI city planner—buying chips, power, and infrastructure while others chase apps. A deep dive into Philippe Laffont’s blueprint for the token economy.
ARKO Corp: The Convenience Store “Squeeze” — Value Trap or Fuel-Injected Turnaround?
ARKO is playing financial Tetris: heavy debt, a fresh spin-off, institutional backing, and a stock still far below its highs. Is this a value trap—or a fuel-injected turnaround?
Davidson Kempner’s 2025: The “Shadow Bank” Pivot & The Deep-Value Sea Change
Davidson Kempner’s 2025 wasn’t about chasing hype—it was about building a shadow bank. From asset-backed credit to tech anchors and restructurings, here’s the fun, smart deep dive.
ARKK 2025: The “Mojo” Is Back (But the Volatility Never Left)
ARKK crushed 2025, face-planted in early 2026, and reminded everyone why Cathie Wood’s fund is the wildest ride in innovation investing. Fun, data-driven, and brutally honest about the volatility.
Viking’s 2025 Scorecard: When the “Tiger Cub” Trades Its Stripes for a Suit
Viking Global’s 2025 wasn’t about fireworks—it was about survival. While the S&P 500 soared, Halvorsen dumped AI glamour and loaded up on banks. Was it a mistake… or a setup for the next cycle?
Two Sigma Investments Scorecard for 2025: The Numbers (Finally) Add Up!
After founder drama and a rogue researcher scandal, Two Sigma still hit $70B in AUM in 2025. Did the quant engine really win? Here’s the fun, honest scorecard behind the numbers.
The $900 Million Gut-Punch: How Israel Englander Saved Millennium’s Year
A $900 million February gut-punch. 330+ trading pods. A 10.5% comeback year. Inside Millennium’s high-speed, kill-switch machine—and what retail investors can actually learn from it.
How Tiger Global Relearned to Hunt in 2025 (And What Investors Can Learn)
After years in the valuation wilderness, Tiger Global came roaring back in 2025. Fewer bets, more conviction, heavy AI infrastructure exposure—and a +33% private fund rebound. Here’s what actually worked, what they cut, and what retail investors can steal from the Tiger’s new playbook. 🐅📈
Balyasny Asset Management’s 2025 Scorecard: Solid Performance, Serious Machine
Balyasny Asset Management posted a strong +16.7% in 2025—but so did the market. This isn’t a story about fireworks. It’s a story about a world-class multi-strategy machine, risk control, and why institutions still pay for discipline, not just beta.
Madrigal, BeiGene, and Biotech Alpha: Inside the “Gene-ius” Kingmakers of Baker Bros. 2025
Biotech Jedi at work. Baker Bros’ 2025 victory lap shows how Madrigal, BeiGene, and ruthless conviction turned science into serious alpha.